Wedbush Securities’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-735
Closed -$92K 1024
2020
Q2
$92K Buy
+735
New +$92K 0.01% 866